Skip to content
value.today

Altor Bioscience Corp

Total raised
$80 M
7 rounds on record
Latest round
$30 M
Mar 2017
First round on record
Oct 2009
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Altor Bioscience Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2017$30 MNo. 7$10 to $50 million

Altor Bioscience Corp: Raise no. 7, Mar 2017

Investors in this round

7 investors had bought by the notice of Mar 22, 2017: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$30 M of $30 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hing C. Wong · Executive Officer, Director
  • Peter S. Rhode · Executive Officer
  • Rick S. Greene · Executive Officer
  • Fred Middleton · Director
  • Patrick Soon-Shiong · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rick S. Greene, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 22, 2017. Read the notice at the SEC.

equitySEC
Jul 2016$20 MNo. 6$10 to $50 million

Altor Bioscience Corp: Raise no. 6, Jul 2016

Investors in this round

1 investor had bought by the notice of Jul 19, 2016: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $45 M offered; $25 M still to sell
Smallest investment taken
$15,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$5,800,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hing C. Wong · Executive Officer, Director
  • Peter S. Rhode · Executive Officer
  • Rick S. Greene · Executive Officer
  • Fred Middleton · Director
  • Patrick Soon-Shiong · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rick S. Greene, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 19, 2016. Read the notice at the SEC.

equitySEC
Oct 2014$11 MNo. 5$10 to $50 million

Altor Bioscience Corp: Raise no. 5, Oct 2014

Investors in this round

1 investor had bought by the notice of Jun 1, 2015: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $11 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hing C Wong · Executive Officer, Director
  • Peter C Rhode · Executive Officer
  • Adam Boyder Waldman · Director
  • C. Boyder Gray · Director
  • Fred C Middleton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Hing C. Wong, President. Source: SEC Form D, newest notice filed Jun 1, 2015. Read the notice at the SEC.

equitySEC
Feb 2013$6 MNo. 4$2 to $10 million

Altor Bioscience Corp: Raise no. 4, Feb 2013

Investors in this round

21 investors had bought by the notice of Mar 14, 2013: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hing C. Wong · Executive Officer, Director
  • Peter C. Rhode · Executive Officer
  • Adam Boyden Waldman · Director
  • C. Boyden Gray · Director
  • Fred C. Middleton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Hing C. Wong, President. Source: SEC Form D, newest notice filed Mar 14, 2013. Read the notice at the SEC.

equitySEC
Jan 2011$11 MNo. 3$10 to $50 million

Altor Bioscience Corp: Raise no. 3, Jan 2011

Investors in this round

29 investors had bought by the notice of Jul 20, 2012: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $11 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bee-Yau C. Huang · Executive Officer
  • Hing C. Wong · Executive Officer, Director
  • Peter C. Rhode · Executive Officer
  • Adam C. Waldman, J.D. · Director
  • C. Boyden Gray · Director
  • Fred C. Middleton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Hing C. Wong, President. Source: SEC Form D and 1 amendment, newest notice filed Jul 20, 2012. Read the notice at the SEC.

equitySEC
Jul 2010$1 MNo. 2Under $2 million

Altor Bioscience Corp: Raise no. 2, Jul 2010

Investors in this round

5 investors had bought by the notice of Jul 26, 2010: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bee-Yau C. Huang · Executive Officer
  • Hing C. Wong · Executive Officer, Director
  • Peter C. Rhode · Executive Officer
  • Adam C. Waldman, J.D. · Director
  • C. Boyden Gray · Director
  • Fred C. Middleton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Hing C. Wong, President. Source: SEC Form D, newest notice filed Jul 26, 2010. Read the notice at the SEC.

equitySEC
Oct 2009$1 MNo. 1Under $2 million

Altor Bioscience Corp: Raise no. 1, Oct 2009

Investors in this round

10 investors had bought by the notice of Oct 22, 2009: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hing C. Wong · Executive Officer, Director
  • Peter C. Rhode · Executive Officer
  • Adam Boydon Waldman · Director
  • C. Boydon Gray · Director
  • Fred C. Middleton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Hing C. Wong, President. Source: SEC Form D, newest notice filed Oct 22, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Altor Bioscience Corp chose not to state its revenue in its newest notice of a funding round (Mar 2017).

    SEC Form D · Mar 2017

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2017

That is all the official record says: Altor Bioscience Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Altor Bioscience Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 29 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Altor Bioscience Corp
NameRoleNamed in
Hing C. WongExecutive officerMar 2017
Peter S. RhodeExecutive officerMar 2017
Rick S. GreeneExecutive officerMar 2017
Hing C WongExecutive officerJun 2015
Peter C RhodeExecutive officerJun 2015
Peter C. RhodeExecutive officerMar 2013
Bee-Yau C. HuangExecutive officerJul 2012
Fred MiddletonDirectorMar 2017
Hing C. WongDirectorMar 2017
Patrick Soon-ShiongDirectorMar 2017
Adam Boyder WaldmanDirectorJun 2015
C. Boyder GrayDirectorJun 2015
Fred C MiddletonDirectorJun 2015
Hing C WongDirectorJun 2015
Adam Boyden WaldmanDirectorMar 2013
C. Boyden GrayDirectorMar 2013
Fred C. MiddletonDirectorMar 2013
Adam C. Waldman, J.D.DirectorJul 2012
Adam Boydon WaldmanDirectorOct 2009
C. Boydon GrayDirectorOct 2009